Related Experiment Video
Updated: Jul 15, 2026

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
Evaluation of Aortic Dilation in Patients With Hypertrophic Cardiomyopathy in a Tertiary Center for Cardiovascular
Tahereh Babaei1,2, Kosar Babaei3, Golnaz Houshmand4
1Department of Cardiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, iums.ac.ir.
Insights
Aortic dilation affects over a quarter of hypertrophic cardiomyopathy (HCM) patients, linked to age and hypertension. Early aortic evaluation in HCM is crucial for managing this complication.
Area of Science:
- Cardiology
- Genetics
- Vascular Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease.
- Aortic dilation is an underrecognized complication of HCM.
- This study investigates aortic dilation prevalence and risk factors in HCM.
Purpose of the Study:
- Determine the prevalence of aortic dilation in HCM patients.
- Identify clinical and echocardiographic factors associated with aortic dilation.
- Assess the relationship between aortic dilation and myocardial fibrosis.
Main Methods:
- Retrospective analysis of 216 adult HCM patients.
- Exclusion of patients with valvular disease, aortic anomalies, or other cardiomyopathies.
- Collection of clinical, echocardiographic, and cardiac MRI data; logistic regression for factor identification.
Main Results:
- 26.3% of patients had ascending aorta dilation; 5.6% had sinus of Valsalva (SOV) dilation.
- Ascending aorta dilation associated with older age, hypertension, increased BSA, and LVESD.
- Independent predictors for ascending aorta dilation: age, hypertension, LVESD, and right ventricular hypertrophy.
Conclusions:
- Aortic dilation is common in HCM patients.
- Associated with age, hypertension, and cardiac remodeling.
- Routine aortic evaluation in HCM patients is recommended for early detection and management.
Background:
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disease primarily affecting the left ventricle. While the disease is traditionally associated with myocardial hypertrophy and left ventricular outflow tract (LVOT) obstruction, aortic dilation has emerged as a potentially serious but underrecognized complication. This study aimed to determine the prevalence of aortic dilation in HCM patients and to identify associated clinical and echocardiographic factors.
Methods:
In this cross-sectional, retrospective study, 216 adult patients diagnosed with HCM at Rajaie Cardiovascular Institute (Tehran, Iran) from 2016 to 2021 were evaluated. Patients with significant valvular disease, congenital aortic anomalies, prior aortic surgery, or other cardiomyopathies were excluded. Clinical data and echocardiographic measurements, including aortic dimensions indexed to body surface area (BSA), were collected. Cardiac magnetic resonance imaging (MRI) data of myocardial fibrosis were also assessed in a subset of patients. Logistic regression was used to identify factors independently associated with aortic dilation.
Results:
Dilated ascending aorta was present in 56 patients (26.3%), while 12 patients (5.6%) had dilation of the sinus of Valsalva (SOV). Dilated ascending aorta was significantly associated with older age (p = 0.001), hypertension (p = 0.001), and increased BSA (p = 0.002). LV end-systolic diameter (LVESD) also showed a significant correlation (p = 0.002). Multivariate analysis identified age (OR = 1.063), hypertension (OR = 5.49), LVESD (OR = 3.25), and right ventricular hypertrophy (OR = 4.99) as independent predictors of ascending aorta dilation. SOV dilation was similarly associated with age (OR = 1.117) and lower weight (OR = 0.915). Although myocardial fibrosis was more common in patients with ascending aorta dilation, this did not reach statistical significance (p = 0.006).
Conclusion:
Aortic dilation is a relatively common finding in patients with HCM and is significantly associated with age, hypertension, and structural cardiac remodeling. Routine evaluation of the ascending aorta and SOV in HCM patients may aid in the early detection and management of this potential complication.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Aneurysm III: Interprofessional Care

